Lung Cancer Patient Registry at Policlinico San Matteo
Part of Cancer, Lungs & breathing clinical trials.
This study collects information from people with lung cancer who are treated at a specific hospital in Italy. The goal is to better understand the disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with lung cancer.
- You are being treated at the SC Oncologia 1 Unit at Fondazione IRCCS Policlinico San Matteo in Pavia.
- You can understand the study and sign a consent form (or a legal guardian can).
- If you are already a patient, you have given permission for your medical data to be used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study of people with lung cancer. The goal is to better understand care patterns and outcomes; joining would involve giving consent and answering study questions.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This study is for people diagnosed with lung cancer at a younger age (under 50). It aims to understand your needs and improve care through a dedicated program. You will be asked to complete surveys about your experience.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This trial is a registry that collects information from people with certain types and stages of lung cancer. It helps researchers understand how these cancers are managed in real life, which can guide better future care.
This study follows adults with confirmed lung cancer as they are diagnosed and treated in routine clinical practice. It aims to better understand how lung cancer is diagnosed and managed day-to-day, which may help improve future care.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.